109 related articles for article (PubMed ID: 10917652)
21. Structure, biochemical and kinetic properties of recombinant Pst2p from Saccharomyces cerevisiae, a FMN-dependent NAD(P)H:quinone oxidoreductase.
Koch K; Hromic A; Sorokina M; Strandback E; Reisinger M; Gruber K; Macheroux P
Biochim Biophys Acta Proteins Proteom; 2017 Aug; 1865(8):1046-1056. PubMed ID: 28499769
[TBL] [Abstract][Full Text] [Related]
22. High-resolution studies of hydride transfer in the ferredoxin:NADP
Kean KM; Carpenter RA; Pandini V; Zanetti G; Hall AR; Faber R; Aliverti A; Karplus PA
FEBS J; 2017 Oct; 284(19):3302-3319. PubMed ID: 28783258
[TBL] [Abstract][Full Text] [Related]
23. Functions of flavin reductase and quinone reductase in 2,4,6-trichlorophenol degradation by Cupriavidus necator JMP134.
Belchik SM; Xun L
J Bacteriol; 2008 Mar; 190(5):1615-9. PubMed ID: 18165297
[TBL] [Abstract][Full Text] [Related]
24. The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol.
Asher G; Dym O; Tsvetkov P; Adler J; Shaul Y
Biochemistry; 2006 May; 45(20):6372-8. PubMed ID: 16700548
[TBL] [Abstract][Full Text] [Related]
25. Purification and crystallization of rat liver NAD(P)H:(quinone-acceptor) oxidoreductase by cibacron blue affinity chromatography: identification of a new and potent inhibitor.
Prochaska HJ
Arch Biochem Biophys; 1988 Dec; 267(2):529-38. PubMed ID: 3214167
[TBL] [Abstract][Full Text] [Related]
26. Preferential utilization of NADPH as the endogenous electron donor for NAD(P)H:quinone oxidoreductase 1 (NQO1) in intact pulmonary arterial endothelial cells.
Bongard RD; Lindemer BJ; Krenz GS; Merker MP
Free Radic Biol Med; 2009 Jan; 46(1):25-32. PubMed ID: 18848878
[TBL] [Abstract][Full Text] [Related]
27. Combined molecular modelling and 3D-QSAR study for understanding the inhibition of NQO1 by heterocyclic quinone derivatives.
López-Lira C; Alzate-Morales JH; Paulino M; Mella-Raipán J; Salas CO; Tapia RA; Soto-Delgado J
Chem Biol Drug Des; 2018 Jan; 91(1):29-38. PubMed ID: 28643389
[TBL] [Abstract][Full Text] [Related]
28. Thermodynamics of cooperative binding of FAD to human NQO1: Implications to understanding cofactor-dependent function and stability of the flavoproteome.
Clavería-Gimeno R; Velazquez-Campoy A; Pey AL
Arch Biochem Biophys; 2017 Dec; 636():17-27. PubMed ID: 29100982
[TBL] [Abstract][Full Text] [Related]
29. Functional interactions in cytochrome P450BM3. Evidence that NADP(H) binding controls redox potentials of the flavin cofactors.
Murataliev MB; Feyereisen R
Biochemistry; 2000 Oct; 39(41):12699-707. PubMed ID: 11027150
[TBL] [Abstract][Full Text] [Related]
30. FAD-binding site and NADP reactivity in human renalase: a new enzyme involved in blood pressure regulation.
Milani M; Ciriello F; Baroni S; Pandini V; Canevari G; Bolognesi M; Aliverti A
J Mol Biol; 2011 Aug; 411(2):463-73. PubMed ID: 21699903
[TBL] [Abstract][Full Text] [Related]
31. Kinetic Characterization of PA1225 from Pseudomonas aeruginosa PAO1 Reveals a New NADPH:Quinone Reductase.
Flores E; Gadda G
Biochemistry; 2018 May; 57(21):3050-3058. PubMed ID: 29715013
[TBL] [Abstract][Full Text] [Related]
32. The C-terminal extension of bacterial flavodoxin-reductases: involvement in the hydride transfer mechanism from the coenzyme.
Bortolotti A; Sánchez-Azqueta A; Maya CM; Velázquez-Campoy A; Hermoso JA; Medina M; Cortez N
Biochim Biophys Acta; 2014 Jan; 1837(1):33-43. PubMed ID: 24016470
[TBL] [Abstract][Full Text] [Related]
33. Differential transfers of reduced flavin cofactor and product by bacterial flavin reductase to luciferase.
Jeffers CE; Tu SC
Biochemistry; 2001 Feb; 40(6):1749-54. PubMed ID: 11327836
[TBL] [Abstract][Full Text] [Related]
34. Enzyme evolution. Déjà vu all over again.
Petsko GA
Nature; 1991 Jul; 352(6331):104-5. PubMed ID: 2067568
[No Abstract] [Full Text] [Related]
35. Modulator of drug activity B from Escherichia coli: crystal structure of a prokaryotic homologue of DT-diaphorase.
Adams MA; Jia Z
J Mol Biol; 2006 Jun; 359(2):455-65. PubMed ID: 16630630
[TBL] [Abstract][Full Text] [Related]
36. Crystal structure of NAD(P)H:flavin oxidoreductase from Escherichia coli.
Ingelman M; Ramaswamy S; Nivière V; Fontecave M; Eklund H
Biochemistry; 1999 Jun; 38(22):7040-9. PubMed ID: 10353815
[TBL] [Abstract][Full Text] [Related]
37. Reduction of nitroaromatic compounds by NAD(P)H:quinone oxidoreductase (NQO1): the role of electron-accepting potency and structural parameters in the substrate specificity.
Miseviciene L; Anusevicius Z; Sarlauskas J; Cenas N
Acta Biochim Pol; 2006; 53(3):569-76. PubMed ID: 16929382
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the quinone reductase activity of the ferric reductase B protein from Paracoccus denitrificans.
Sedlácek V; van Spanning RJ; Kucera I
Arch Biochem Biophys; 2009 Mar; 483(1):29-36. PubMed ID: 19138657
[TBL] [Abstract][Full Text] [Related]
39. Reduction of chromium(VI) to chromium(V) by rat liver cytosolic and microsomal fractions: is DT-diaphorase involved?
Aiyar J; De Flora S; Wetterhahn KE
Carcinogenesis; 1992 Jul; 13(7):1159-66. PubMed ID: 1379126
[TBL] [Abstract][Full Text] [Related]
40. Flavin conformational changes in the catalytic cycle of p-hydroxybenzoate hydroxylase substituted with 6-azido- and 6-aminoflavin adenine dinucleotide.
Palfey BA; Ballou DP; Massey V
Biochemistry; 1997 Dec; 36(50):15713-23. PubMed ID: 9398300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
